Clinical trials
Observational Cardiotoxicity trials in China
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
12 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2019 | 4 |
| 2020 | 1 |
| 2021 | 4 |
| 2023 | 2 |
| 2024 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Unknown status | 8 |
| Recruiting | 2 |
| Active, not recruiting | 1 |
| Completed | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Peking University Third Hospital | 3 |
| Affiliated Hospital of Qinghai University | 1 |
| Air Force Military Medical University, China | 1 |
| First Hospital of China Medical University | 1 |
| Kai Mu | 1 |
| Peking University Cancer Hospital & Institute | 1 |
| Qianfoshan Hospital | 1 |
| Second Affiliated Hospital, Zhejiang University, School of Medicine | 1 |
| Sun Yat-sen University | 1 |
| West China Second University Hospital | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Cardiotoxicity | 12 |
| Breast Neoplasms | 3 |
| Altitude Sickness | 1 |
| Carcinoma, Non-Small-Cell Lung | 1 |
| Neoplasms | 1 |
| Osteosarcoma | 1 |
Trials
Showing 1 to 12 of 12. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.